Future studies investigating treatment responses and outcome in ITPR1-related autoimmunity should systematically evaluate ITPR1-IgG/anti-Sj subclasses, given that the presence of exclusively IgG2 antibodies was associated with a milder course of disease in some cases compared to patients with predominantly IgG1 antibodies. The gene discussed is ITPR1; the disease is Autoimmunity.